Active Ingredient: BUDESONIDE
Proprietary Name: TARPEYO
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: 4MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215935
Product Number: 001
Approval Date: Dec 15, 2021
Applicant Holder Full Name: CALLIDITAS THERAPEUTICS AB
Marketing Status:
Prescription
Patent and Exclusivity Information
